• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY MITEK LLC US 4.75 HEALIX ADVANCE KNTLSS BR; SOFT-TISSUE ANCHOR, BIOABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY MITEK LLC US 4.75 HEALIX ADVANCE KNTLSS BR; SOFT-TISSUE ANCHOR, BIOABSORBABLE Back to Search Results
Catalog Number 222330
Device Problem Migration or Expulsion of Device (1395)
Patient Problems Injury (2348); Not Applicable (3189)
Event Date 01/15/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.(b)(4).
 
Event Description
It was reported by the affiliate via email that the anchor was backed out when the surgeon applied the tension to the suture during an arcr surgery.The anchor tip got the crack, so that the surgeon attempted to implant the anchor by using alternative anchor.However, the alternative anchor was also backed out so that the surgeon attempted to implant the 3rd anchor with different bone hole to be opened.Then, the 3rd anchor was also broken at the tip of the anchor.Finally, the surgeon used alternative anchor to complete the surgery.It was brand new and the first use when the issue occurred.There was less than 30min.Surgical delay and no harm to the patient.Additional information received from the affiliate on 01/24/2019 reporting that the impacted devices would not be returning to depuy mitek for evaluation.
 
Manufacturer Narrative
Product complaint # (b)(4).Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Investigation summary: the complaint indicates that the device will not be returned and therefore not available for evaluation.No further information regarding the cause of the defect has been provided to help determine a root cause for this failure.This complaint cannot be confirmed.We cannot discern a root cause for the reported failure mode.No nonconformances were identified for this part number, serial number combination.Review conducted per qlik query executed on 2/13/2019.At this point in time, no corrective action is required, and no further action is warranted.However, depuy synthes mitek will continue to track any related complaints within this device family as a means of monitoring the extent with which this complaint is observed in the field.Udi: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
4.75 HEALIX ADVANCE KNTLSS BR
Type of Device
SOFT-TISSUE ANCHOR, BIOABSORBABLE
Manufacturer (Section D)
DEPUY MITEK LLC US
325 paramount drive
raynham MA 02767
MDR Report Key8333606
MDR Text Key136021786
Report Number1221934-2019-56388
Device Sequence Number1
Product Code MAI
UDI-Device Identifier10886705023462
UDI-Public10886705023462
Combination Product (y/n)N
PMA/PMN Number
K130917
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other
Type of Report Initial,Followup
Report Date 01/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2021
Device Catalogue Number222330
Device Lot NumberL883012
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/17/2019
Initial Date FDA Received02/12/2019
Supplement Dates Manufacturer Received02/13/2019
Supplement Dates FDA Received02/14/2019
Patient Sequence Number1
-
-